Trilinear BioVentures, LLC Logo

An emerging biotechnology leader for the early diagnosis of sepsis, Trilinear Bioventures is changing today’s standard of patient care. Our novel platform quickly and non-invasively detects a patient’s risk of sepsis and continuously monitors infection status and response to treatment.

Our disruptive integration of state-of-the-art optical biosensor technology, cutting-edge advancements in microvascular science, and exploding growth of big data applications is supported by more than five years of research and development by a Fortune 500 international technology manufacturer, renown medical experts, and a portfolio of over 25 U.S. patents.

Trilinear is delivering an indispensable front-line diagnostic and patient monitoring solution that will revolutionize the next generation of personalized medicine.

Visit us on the campus of HudsonAlpha Institute for Biotechnology

Trilinear BioVentures on the campus of Hudson Alpha Institute for Biotechnology
Trilinear BioVentures, LLC™
Please Email or Call
601 Genome Way, Suite 2003
Huntsville, AL 35806
(256) 210-1199